Islet adaptations in fetal sheep persist following chronic exposure to high norepinephrine.
AffiliationUniv Arizona, Sch Anim & Comparat Biomed Sci
Univ Arizona, Dept Physiol
MetadataShow full item record
CitationIslet adaptations in fetal sheep persist following chronic exposure to high norepinephrine. 2017, 232 (2):285-295 J. Endocrinol.
JournalThe Journal of endocrinology
Rights© 2017 Society for Endocrinology
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractComplications in pregnancy elevate fetal norepinephrine (NE) concentrations. Previous studies in NE-infused sheep fetuses revealed that sustained exposure to high NE resulted in lower expression of α2-adrenergic receptors in islets and increased insulin secretion responsiveness after acutely terminating the NE infusion. In this study, we determined if the compensatory increase in insulin secretion after chronic elevation of NE is independent of hyperglycemia in sheep fetuses and whether it is persistent in conjunction with islet desensitization to NE. After an initial assessment of glucose-stimulated insulin secretion (GSIS) at 129 ± 1 days of gestation, fetuses were continuously infused for seven days with NE and maintained at euglycemia with a maternal insulin infusion. Fetal GSIS studies were performed again on days 8 and 12. Adrenergic sensitivity was determined in pancreatic islets collected at day 12. NE infusion increased (P < 0.01) fetal plasma NE concentrations and lowered (P < 0.01) basal insulin concentrations compared to vehicle-infused controls. GSIS was 1.8-fold greater (P < 0.05) in NE-infused fetuses compared to controls at both one and five days after discontinuing the infusion. Glucose-potentiated arginine-induced insulin secretion was also enhanced (P < 0.01) in NE-infused fetuses. Maximum GSIS in islets isolated from NE-infused fetuses was 1.6-fold greater (P < 0.05) than controls, but islet insulin content and intracellular calcium signaling were not different between treatments. The half-maximal inhibitory concentration for NE was 2.6-fold greater (P < 0.05) in NE-infused islets compared to controls. These findings show that chronic NE exposure and not hyperglycemia produce persistent adaptations in pancreatic islets that augment β-cell responsiveness in part through decreased adrenergic sensitivity.
Note12 month embargo; accepted preprint published online 25 November 2016
PubMed Central ID5173394
VersionFinal accepted manuscript
SponsorsNational Institute of Health [R01DK084842]; National Natural Science Foundation of China (NSFC) ; Chongqing Science and Technology Commission, Chongqing, China [CSTC2014JCYJA80036]; Southwest University ; [T32HL7249]
- Enhanced insulin secretion responsiveness and islet adrenergic desensitization after chronic norepinephrine suppression is discontinued in fetal sheep.
- Authors: Chen X, Green AS, Macko AR, Yates DT, Kelly AC, Limesand SW
- Issue date: 2014 Jan 1
- Chronic exposure to elevated norepinephrine suppresses insulin secretion in fetal sheep with placental insufficiency and intrauterine growth restriction.
- Authors: Leos RA, Anderson MJ, Chen X, Pugmire J, Anderson KA, Limesand SW
- Issue date: 2010 Apr
- A Chronic Fetal Leucine Infusion Potentiates Fetal Insulin Secretion and Increases Pancreatic Islet Size, Vascularity, and β Cells in Late-Gestation Sheep.
- Authors: Boehmer BH, Brown LD, Wesolowski SR, Hay WW, Rozance PJ
- Issue date: 2020 Aug 1
- Chronic Fetal Leucine Infusion Does Not Potentiate Glucose-Stimulated Insulin Secretion or Affect Pancreatic Islet Development in Late-Gestation Growth-Restricted Fetal Sheep.
- Authors: Boehmer BH, Wesolowski SR, Brown LD, Rozance PJ
- Issue date: 2021 Feb 1
- Reduced glucose-stimulated insulin secretion following a 1-wk IGF-1 infusion in late gestation fetal sheep is due to an intrinsic islet defect.
- Authors: White A, Stremming J, Boehmer BH, Chang EI, Jonker SS, Wesolowski SR, Brown LD, Rozance PJ
- Issue date: 2021 Jun 1